Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (67)

51

Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial

Erschienen: 2013

von Benhamou, Y. | Moussalli, J. | Ratziu, V. | +7

52

Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure : results from the REALIZE trial

enthalten in: Hepatology (Baltimore, Md.) | 2012

von De Meyer, S. | Dierynck, I. | Ghys, A. | +8

53

Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITAN

enthalten in: Current HIV research | 2012

von Bánhegyi, D. | Katlama, C. | da Cunha, C. | +7

54

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials

enthalten in: PloS one | 2012

von Kieffer, T. | De Meyer, S. | Bartels, D. | +17

55

Telaprevir for retreatment of HCV infection

enthalten in: The New England journal of medicine | 2011

von Zeuzem, S. | Andreone, P. | Pol, S. | +123

CommentIn: J Hepatol. 2011 Dec;55(6):1457-60. - PMID 21835142

56

Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study : 96-week analysis

enthalten in: Antiviral therapy | 2011

von Lathouwers, E. | De Meyer, S. | Dierynck, I. | +4

57

Short communication : activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data

enthalten in: AIDS research and human retroviruses | 2010

von Vingerhoets, J. | Azijn, H. | Tambuyzer, L. | +7

58

Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials

enthalten in: AIDS (London, England) | 2010

von Peeters, M. | Vingerhoets, J. | Tambuyzer, L. | +4

59

Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2010

von Visser, M. | Baert, L. | Klooster, G. | +8

60

In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients

enthalten in: Antiviral therapy | 2010

von Dierynck, I. | De Meyer, S. | Lathouwers, E. | +5